239 related articles for article (PubMed ID: 20525694)
1. The N terminus of Cbl-c regulates ubiquitin ligase activity by modulating affinity for the ubiquitin-conjugating enzyme.
Ryan PE; Sivadasan-Nair N; Nau MM; Nicholas S; Lipkowitz S
J Biol Chem; 2010 Jul; 285(31):23687-98. PubMed ID: 20525694
[TBL] [Abstract][Full Text] [Related]
2. Regulation of ubiquitin protein ligase activity in c-Cbl by phosphorylation-induced conformational change and constitutive activation by tyrosine to glutamate point mutations.
Kassenbrock CK; Anderson SM
J Biol Chem; 2004 Jul; 279(27):28017-27. PubMed ID: 15117950
[TBL] [Abstract][Full Text] [Related]
3. SLAP2 Adaptor Binding Disrupts c-CBL Autoinhibition to Activate Ubiquitin Ligase Function.
Wybenga-Groot LE; Tench AJ; Simpson CD; Germain JS; Raught B; Moran MF; McGlade CJ
J Mol Biol; 2021 Apr; 433(8):166880. PubMed ID: 33617900
[TBL] [Abstract][Full Text] [Related]
4. Autoinhibition and phosphorylation-induced activation mechanisms of human cancer and autoimmune disease-related E3 protein Cbl-b.
Kobashigawa Y; Tomitaka A; Kumeta H; Noda NN; Yamaguchi M; Inagaki F
Proc Natl Acad Sci U S A; 2011 Dec; 108(51):20579-84. PubMed ID: 22158902
[TBL] [Abstract][Full Text] [Related]
5. Requirements of multiple domains of SLI-1, a Caenorhabditis elegans homologue of c-Cbl, and an inhibitory tyrosine in LET-23 in regulating vulval differentiation.
Yoon CH; Chang C; Hopper NA; Lesa GM; Sternberg PW
Mol Biol Cell; 2000 Nov; 11(11):4019-31. PubMed ID: 11071924
[TBL] [Abstract][Full Text] [Related]
6. Structural Determinants of the Gain-of-Function Phenotype of Human Leukemia-associated Mutant CBL Oncogene.
Nadeau SA; An W; Mohapatra BC; Mushtaq I; Bielecki TA; Luan H; Zutshi N; Ahmad G; Storck MD; Sanada M; Ogawa S; Band V; Band H
J Biol Chem; 2017 Mar; 292(9):3666-3682. PubMed ID: 28082680
[TBL] [Abstract][Full Text] [Related]
7. Fyn associates with Cbl and phosphorylates tyrosine 731 in Cbl, a binding site for phosphatidylinositol 3-kinase.
Hunter S; Burton EA; Wu SC; Anderson SM
J Biol Chem; 1999 Jan; 274(4):2097-106. PubMed ID: 9890970
[TBL] [Abstract][Full Text] [Related]
8. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase.
Joazeiro CA; Wing SS; Huang H; Leverson JD; Hunter T; Liu YC
Science; 1999 Oct; 286(5438):309-12. PubMed ID: 10514377
[TBL] [Abstract][Full Text] [Related]
9. CD2-associated protein (CD2AP) enhances casitas B lineage lymphoma-3/c (Cbl-3/c)-mediated Ret isoform-specific ubiquitination and degradation via its amino-terminal Src homology 3 domains.
Calco GN; Stephens OR; Donahue LM; Tsui CC; Pierchala BA
J Biol Chem; 2014 Mar; 289(11):7307-19. PubMed ID: 24425877
[TBL] [Abstract][Full Text] [Related]
10. Yeast two-hybrid in vivo association of the Src kinase Lyn with the proto-oncogene product Cbl but not with the p85 subunit of PI 3-kinase.
Dombrosky-Ferlan PM; Corey SJ
Oncogene; 1997 May; 14(17):2019-24. PubMed ID: 9160881
[TBL] [Abstract][Full Text] [Related]
11. Cbl-b, a member of the Sli-1/c-Cbl protein family, inhibits Vav-mediated c-Jun N-terminal kinase activation.
Bustelo XR; Crespo P; López-Barahona M; Gutkind JS; Barbacid M
Oncogene; 1997 Nov; 15(21):2511-20. PubMed ID: 9399639
[TBL] [Abstract][Full Text] [Related]
12. A conserved DpYR motif in the juxtamembrane domain of the Met receptor family forms an atypical c-Cbl/Cbl-b tyrosine kinase binding domain binding site required for suppression of oncogenic activation.
Peschard P; Ishiyama N; Lin T; Lipkowitz S; Park M
J Biol Chem; 2004 Jul; 279(28):29565-71. PubMed ID: 15123609
[TBL] [Abstract][Full Text] [Related]
13. Src-catalyzed phosphorylation of c-Cbl leads to the interdependent ubiquitination of both proteins.
Yokouchi M; Kondo T; Sanjay A; Houghton A; Yoshimura A; Komiya S; Zhang H; Baron R
J Biol Chem; 2001 Sep; 276(37):35185-93. PubMed ID: 11448952
[TBL] [Abstract][Full Text] [Related]
14. Regulation of Cbl phosphorylation by the Abl tyrosine kinase and the Nck SH2/SH3 adaptor.
Miyoshi-Akiyama T; Aleman LM; Smith JM; Adler CE; Mayer BJ
Oncogene; 2001 Jul; 20(30):4058-69. PubMed ID: 11494134
[TBL] [Abstract][Full Text] [Related]
15. The Ubiquitin Ligases c-Cbl and Cbl-b Negatively Regulate Platelet-derived Growth Factor (PDGF) BB-induced Chemotaxis by Affecting PDGF Receptor β (PDGFRβ) Internalization and Signaling.
Rorsman C; Tsioumpekou M; Heldin CH; Lennartsson J
J Biol Chem; 2016 May; 291(22):11608-18. PubMed ID: 27048651
[TBL] [Abstract][Full Text] [Related]
16. Identification and functional characterization of an Src homology domain 3 domain-binding site on Cbl.
Sanjay A; Miyazaki T; Itzstein C; Purev E; Horne WC; Baron R
FEBS J; 2006 Dec; 273(23):5442-56. PubMed ID: 17094785
[TBL] [Abstract][Full Text] [Related]
17. Cbl-c ubiquitin ligase activity is increased via the interaction of its RING finger domain with a LIM domain of the paxillin homolog, Hic 5.
Ryan PE; Kales SC; Yadavalli R; Nau MM; Zhang H; Lipkowitz S
PLoS One; 2012; 7(11):e49428. PubMed ID: 23145173
[TBL] [Abstract][Full Text] [Related]
18. Cbl-b, a RING-type E3 ubiquitin ligase, targets phosphatidylinositol 3-kinase for ubiquitination in T cells.
Fang D; Wang HY; Fang N; Altman Y; Elly C; Liu YC
J Biol Chem; 2001 Feb; 276(7):4872-8. PubMed ID: 11087752
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine phosphorylation and complex formation of Cbl-b upon T cell receptor stimulation.
Elly C; Witte S; Zhang Z; Rosnet O; Lipkowitz S; Altman A; Liu YC
Oncogene; 1999 Feb; 18(5):1147-56. PubMed ID: 10022120
[TBL] [Abstract][Full Text] [Related]
20. A dynamic constitutive and inducible binding of c-Cbl by PLCgamma1 SH3 and SH2 domains (negatively) regulates antigen receptor-induced PLCgamma1 activation in lymphocytes.
Rellahan BL; Graham LJ; Tysgankov AY; DeBell KE; Veri MC; Noviello C; Bonvini E
Exp Cell Res; 2003 Sep; 289(1):184-94. PubMed ID: 12941616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
